Regulation 64 Distance selling premises: specific conditions
United Kingdom
Paragraph (2) applies where—
an application in respect of distance selling premises is granted under these Regulations; or
an application was granted under the 2005 Regulations or 2012 Regulations in respect of premises which were, for the purposes of the Regulations under which the application was granted, distance selling premises.
The inclusion in the pharmaceutical list of the person (X) listed in relation to—
those distance selling premises; or
if there has been a relocation of the retail pharmacy business or appliance contractor business at those distance selling premises to other premises, those other premises,
is subject to the conditions set out in paragraph (3).
Those conditions are—
X must not offer to provide pharmaceutical services F2... to persons who are present at (which includes in the vicinity of) the listed chemist premises;
the means by which X provides pharmaceutical services F3... must be such that any person receiving those services does so otherwise than at the listed chemist premises;
the listed chemist premises must not be on the same site or in the same building as the premises of a provider of primary medical services with a patient list;
in the case of pharmacy premises, the pharmacy procedures for the premises must be such as to secure—
the uninterrupted provision of essential services, during the opening hours of the premises, to persons anywhere in England who request those services, and
nothing F6... in X's publicity material in respect of the listed chemist premises, in material published on behalf of X publicising services provided at or from the listed chemist premises or in any communication (written or oral) from X or X's staff to any person seeking the provision of essential services from X must represent, either expressly or impliedly, that—
the essential services provided at or from the premises are only available to persons in particular areas of England, or
X is likely to refuse, for reasons other than those provided for in X's terms of service, to provide drugs or appliances ordered on prescription forms or repeatable prescription forms which are presented by particular categories of patients (for example, because the availability of essential services from X is limited to other categories of patients).
Notwithstanding the amendments to paragraph (3) which come into force on 1st October 2025, until the end of 31st March 2026 paragraph (3) remains in force as it had effect before those amendments were made, but only in so far as is necessary to give effect to paragraph (3B).
At distance selling premises listed in relation to X before 1st October 2025, X may until the end of 31st March 2026 provide directed services that consist of the supply or administration of a prescription only medicine used for vaccination or immunisation against coronavirus or influenza virus (but no other directed services).
F8NHS England may not vary or remove the conditions set out in paragraph (3).
Annotations
Textual amendments
- F1
Reg. 64(1) substituted (1.4.2014) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment and Transitional Provision) Regulations 2014 (S.I. 2014/417), regs. 1, 15
- F2
Words in reg. 64(3)(a) omitted (1.10.2025) by virtue of The National Health Service (Charges, Remission of Charges and Pharmaceutical Services etc.) (Amendment and Transitional Provisions) Regulations 2025 (S.I. 2025/636), regs. 1(3), 9(2)
- F3
Words in reg. 64(3)(b) omitted (1.10.2025) by virtue of The National Health Service (Charges, Remission of Charges and Pharmaceutical Services etc.) (Amendment and Transitional Provisions) Regulations 2025 (S.I. 2025/636), regs. 1(3), 9(2)
- F4
Words in reg. 64(3)(d)(ii) substituted (1.10.2025) by The National Health Service (Charges, Remission of Charges and Pharmaceutical Services etc.) (Amendment and Transitional Provisions) Regulations 2025 (S.I. 2025/636), regs. 1(3), 9(3)(a)
- F5
Words in reg. 64(3)(d)(ii) inserted (1.10.2025) by The National Health Service (Charges, Remission of Charges and Pharmaceutical Services etc.) (Amendment and Transitional Provisions) Regulations 2025 (S.I. 2025/636), regs. 1(3), 9(3)(b)
- F6
Words in reg. 64(3)(e) omitted (1.10.2025) by virtue of The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 62
- F7
Reg. 64(3A)(3B) inserted (1.10.2025) by The National Health Service (Charges, Remission of Charges and Pharmaceutical Services etc.) (Amendment and Transitional Provisions) Regulations 2025 (S.I. 2025/636), regs. 1(3), 9(4)
- F8
Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1
Modifications
- C1
Reg. 64(3)(c) excluded (1.4.2014) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment and Transitional Provision) Regulations 2014 (S.I. 2014/417), regs. 1, 16